Citation:Ocque R, Tochigi N, Ohori NP, Dacic S 2011

From Cancer Guidelines Wiki

Citation


Ocque R, Tochigi N, Ohori NP, Dacic S. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Am J Clin Pathol 2011 Jul;136(1):81-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21685035.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Ocque R, Tochigi N, Ohori NP, Dacic S 2011When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Ocque_R,_Tochigi_N,_Ohori_NP,_Dacic_S_2011&oldid=107032"